Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

Chemistry World November 22, 2010 Akshat Rathi	Irish drug industry fears bailout tax terms Any increase in Ireland's corporation tax rate as part of a financial bailout could hurt the country's rapidly expanding pharmaceutical industry, currently its largest contributor to corporation tax.
Chemistry World August 7, 2012 Anthony King	Irish pharma exports tumble Irish pharma exports to the US declined 30% in the first six months of this year as a clatter of blockbuster drugs made in Ireland, such as Lipitor (atorvastatin), came off patent.
BusinessWeek September 27, 2004 Kerry Capell	How Dublin Keeps Big Pharma Happy By providing cheap yet educated workers and giving tax breaks to big investors, the Irish have turned their country into a major drug manufacturing center.
Pharmaceutical Executive June 1, 2013	Country Report: Ireland Ireland has been a pharma industry darling since the 1960s, when a then-newly established IDA targeted the sector as a strategic area for development. Today, the numbers are eye catching.
Bio-IT World April 2006 Samara McCarthy	Ireland's Biotech Boom How the Emerald Isle has made its name in the life sciences.
Chemistry World June 24, 2011 Andrew Turley	Pfizer to Keep 350 Jobs at Sandwich US drug giant Pfizer has said that it will keep 350 jobs at its site in Sandwich, UK.
Pharmaceutical Executive September 1, 2008	How Do You Solve a Problem Like Manufacturing? Outsourcing saves pharmaceutical companies money -- except when it doesn't. Here's how to decide what to do.
Pharmaceutical Executive September 1, 2014 William Looney	Ireland's Celtic Tiger: Back on the Hunt Leaders from industry, government, and the CRO community examine Ireland's future as a magnet for life science investments, and what the nation must do to remain the leading exporter of finished pharmaceutical products.
CFO June 1, 2011 Janet Kersnar	Back on the Map Ireland's domestic economy may be in shambles, but expansion-minded U.S. firms see plenty of opportunity there.
Chemistry World December 22, 2010 Sarah Houlton	Fines, Flu and an Uncertain Future It was another tough year for the pharma industry, with downsizing, pricing concerns and the impending expiration of patents on many products. But some of the biggest headlines were caused by eye-watering fines dished out in the US.
Chemistry World December 22, 2011 Sarah Houlton	Pharma braces for patent cliff impact It remains to be seen quite how far Lipitor sales will fall. Ranbaxy has six months of exclusivity for generic competition.
Chemistry World December 15, 2009 Sarah Houlton	Pharma's year of merger mania Away from the corporate world, the big pharma story of 2009 was the emergence of a new health scare - swine flu.
BusinessWeek September 27, 2004	Eminent Minds on the Emerald Isle The Irish proved they aren't afraid to go across the Atlantic when they hired William C. Harris, a 19-year veteran of the U.S. National Science Foundation, to head the government's fledgling Science Foundation Ireland in 2001.
Chemistry World April 8, 2014 Emma Stoye	Contamination troubles strike GSK Pharma giant GlaxoSmithKline has been warned by the US Food and Drug Administration to address manufacturing problems at the SmithKline Beecham chemical plant in Cork, Ireland, after FDA inspectors found evidence of contamination.
Pharmaceutical Executive April 1, 2006 Ron Feemster	Thought Leader: Q&A with Joel A. Tune Pharma still enlists contract manufacturers as safety valves, but today's drug developers have also begun to outsource the production of increasingly complicated compounds while they are still in clinical trials.
Chemistry World November 11, 2014 Phillip Broadwith	Perrigo to buy Omega Pharma for euro 3.6bn The former US-based Perrigo, which reincorporated in Ireland for tax reasons after buying Elan in 2013, will make use of Omega's established distribution networks in Europe to further expand its geographic reach.
IndustryWeek December 1, 2005 Traci Purdum	Microsoft Makes It a Double Redmond, Wash.-based Microsoft Corp. is investing $65 million to expand its presence in Humacao, Puerto Rico, to position itself as a "growth center" for Microsoft of the Americas through manufacturing and exporting CDs and DVDs.
The Motley Fool November 4, 2011 Matt Koppenheffer	Ireland Continues Turning the Screws ... on Itself Ireland is planning $17 billion of additional austerity measures over the next four years as the country continues to grapple with a heavy debt load and a slowing economy.
Bank Systems & Technology February 27, 2009 Orla O'Sullivan	Millions Walk From Irish Bank Amid Shoddy Security Public outcry in Ireland that an estimated 7 million Euro was stolen from the country's biggest bank because of poor procedures.
The Motley Fool November 30, 2011 Isaac Pino	I Was Wrong About Ireland The Celtic Tiger economy exited as quickly as it arrived on the Emerald Isle.
Pharmaceutical Executive June 1, 2013 Julian Upton	Opening the Patent Box Are the answers to the UK pharma sector's problems to be found in the government's new "Patent Box," which introduces a lower rate of corporation tax on profits generated from UK-owned intellectual property.
Chemistry World February 2012	Navigating the stormy seas of pharma In the pharmaceutical and biotech sector, quality navigation is becoming an essential process for identifying the best route to take in order to guide business effectively in a dramatically changing environment.
IndustryWeek March 1, 2008 David Blanchard	Just In Time -- Buddy, Can You Spare a Job? U.S. manufacturers assert their continuing relevance despite a decline in overall employment and a lack of commitment from politicians.
Chemistry World July 31, 2013 Daniel Johnson	Perrigo bags Elan and its bargain Irish tax rates US drugmaker Perrigo has agreed to buy Irish pharma company Elan in a deal worth $8.6 billion. This hands Perrigo a base in low-tax Ireland and annual savings of up to $150 million in tax and operating costs.
Chemistry World January 20, 2012 Sarah Houlton	Takeda slashes 10% of its workforce This represents about 10% of its workforce, and the cuts will be made in research, commercial and admin sections of the business.
Pharmaceutical Executive January 1, 2011	The Steep, Slow Climb A survey of leading experts reveals 2011's sobering reality and the trends that smart drugmakers will follow into the next decade.
IndustryWeek March 1, 2008 David Blanchard	Manufacturing Is Not For the Faint at Heart -- IndustryWeek's 2008 Salary Survey Comments When asked to comment on the state of the industry, manufacturing managers throughout the United States share a common concern that the odds seem to be stacked against them.
Chemistry World October 23, 2008 Matt Wilkinson	Merck to slash more jobs Beleaguered US pharma giant, Merck & Co., has announced new restructuring plans that will see the company cut 7,200 jobs in an effort to save up to $4.2 billion
The Motley Fool April 13, 2011 Jordan DiPietro	Ireland's Race Toward Catastrophe Things keep worsening for the Emerald Isle's banks.
The Motley Fool April 7, 2011 Sean Williams	Portugal Reminds Us That You Can't Triple-Stamp a Double Stamp Portugal is the third European Union member in less than a year seeking financial assistance from the European Central Bank.
Chemistry World December 8, 2011 Sarah Houlton	Academia Grows Its Role in Drug Discovery The number of pharma patents being filed by universities around the world is soaring compared with those coming from industry.
IndustryWeek September 14, 2011	Wanted: Talent-Driven Innovation Can the United States meet the challenge of creating the skilled workforce needed for manufacturing leadership?
Chemistry World September 17, 2007	Uk Pharma Shifts Manufacturing Overseas Drug firm AstraZeneca has today reiterated that it will outsource drug manufacturing.
IndustryWeek July 1, 2004 Karen M. Kroll	Life On The Island The life sciences industry taps Puerto Rico for tax breaks, educated workforce.
Bio-IT World June 15, 2003 Bob Violino	Mid-Atlantic/Southeast Region Maryland: Making a Federal Case for Biotechnology... Puerto Rico: Isle of Incentives... Virginia: Planting Needed Seed Capital... North Carolina: Triangulating Biotech Resources... Florida: Shining Resources on Small Biotech Sector
The Motley Fool December 19, 2005 Stephen D. Simpson	Pfizer Wins, a Sector Rejoices The pharmaceutical dodges a bullet and investors find renewed enthusiasm for big-cap pharma.
BusinessWeek October 14, 2010 Fahy & Flynn	Ireland's Unemployed Head Back to the Farm Ireland has a 13.8 percent jobless rate, but the food sector is thriving.
The Motley Fool September 7, 2010 Gerard Torres	Sovereign Debt Crisis Continued: Irish Banks The downgrade of Ireland's credit rating has a large impact on Irish banks.
Pharmaceutical Executive September 1, 2010	Explaining the Drug Drought Industry needs to engage in a broader public debate on ways to rekindle the innovative engine in new drug discovery and development.
BusinessWeek November 29, 2004 Catherine Arnst	Big Pharma's Blinders Hugely profitable thanks to a few blockbusters, Big Pharma is far too focused on looking for the next best-seller, causing companies to pass up opportunities to deliver important breakthroughs.
On Wall Street February 1, 2011 Milton Ezrati	Europe's Debt Crisis Continues, Despite Ireland's Resolved Debt No one will find a way to rest easy about european finances for a long time to come.
Bank Systems & Technology March 15, 2009 Orla O'Sullivan	Irish Banks Reeling From Bursting of Property Bubble Declining property values have sent Ireland's banking industry -- and economy -- into a downward spiral. But bank consolidation and automation efforts may help the small island's financial technology sector regain its footing.
The Motley Fool May 12, 2005 Stephen D. Simpson	Should You Bank on Ireland? Bank of Ireland is doing fine, but it may not be the best stock pick on the Emerald Isle.
The Motley Fool September 9, 2004 Charly Travers	The Case for Drug Stocks The reports of the drug industry's death are greatly exaggerated.
BusinessWeek November 24, 2010 Heatley & Gotkine	Battered Ireland Clings to Its Low Taxes Though Ireland needs $115 billion, it says its 12.5 percent corporate tax rate is "non-negotiable"
BusinessWeek February 11, 2010 Kerry Capell	The New Generation Leaving Ireland Some 170,000 jobs vanished last year, and the lack of employment is driving a generation away.
The Motley Fool March 8, 2011 Sean Williams	Forget Oil; This Is What You Should Really Be Worried About Don't look now, but 10-year bond rates in Europe are creeping dangerously higher yet again.
IndustryWeek September 1, 2006 David Blanchard	Just In Time -- Labor Daze: How Do You Define Leadership? With fewer and fewer skilled workers in their ranks, manufacturing leaders are still expected to lead their troops to victory.
Inc. May 1, 2002 Kenneth Klee	The Industry You Can't Afford to Miss After more than two decades of hype, hope, disappointment, and progress, the hundreds of mostly small, money-burning companies that make up the biotech industry are experiencing a decisive shift in their relationship with the giant, rich pharmaceutical companies...
National Defense June 2010 Lawrence P. Farrell Jr.	Defense Manufacturing: A Crisis in the Making Defense manufacturing is like the weather. Everyone talks about it, but no one does anything.